SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1f3l'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	11GS_A_EAAA211_1 (GLUTATHIONE S-TRANSFERASE)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	4 / 7	TYR A 330 PHE A 334 ILE A 226 TYR A 221	None None None SAH A 529 (-3.5A)	0.78A	11gsA-1f3lA: undetectable	11gsA-1f3lA: 19.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	11GS_B_EAAB211_1 (GLUTATHIONE S-TRANSFERASE)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	4 / 7	TYR A 330 PHE A 334 ILE A 226 TYR A 221	None None None SAH A 529 (-3.5A)	0.78A	11gsB-1f3lA: undetectable	11gsB-1f3lA: 19.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1A29_A_TFPA153_1 (CALMODULIN)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	4 / 8	ILE A 303 LEU A 299 ALA A 270 VAL A 278	None	0.74A	1a29A-1f3lA: undetectable	1a29A-1f3lA: 16.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YAJ_A_BEZA11_0 (CES1 PROTEIN)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	4 / 4	LEU A 364 SER A 433 LEU A 518 LEU A 437	None	1.06A	1yajA-1f3lA: 1.5	1yajA-1f3lA: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZUC_B_T98B202_1 (PROGESTERONE RECEPTOR)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	5 / 12	LEU A 527 LEU A 512 LEU A 429 THR A 480 PHE A 482	None	1.11A	1zucB-1f3lA: undetectable	1zucB-1f3lA: 20.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2GSS_A_EAAA0_1 (GLUTATHIONE S-TRANSFERASE P1-1)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	4 / 8	TYR A 330 PHE A 334 ILE A 226 TYR A 221	None None None SAH A 529 (-3.5A)	0.80A	2gssA-1f3lA: undetectable	2gssA-1f3lA: 19.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2GSS_B_EAAB0_1 (GLUTATHIONE S-TRANSFERASE P1-1)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	4 / 8	TYR A 330 PHE A 334 ILE A 226 TYR A 221	None None None SAH A 529 (-3.5A)	0.80A	2gssB-1f3lA: undetectable	2gssB-1f3lA: 19.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2NMZ_B_ROCB401_1 (PROTEASE)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	6 / 12	LEU A 287 ASP A 282 GLY A 260 ILE A 226 ILE A 265 ILE A 286	None SAH A 529 (-2.7A) SAH A 529 (-3.1A) None SAH A 529 (-4.9A) None	1.35A	2nmzA-1f3lA: undetectable	2nmzA-1f3lA: 16.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OAX_A_SNLA1001_1 (MINERALOCORTICOID RECEPTOR)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	5 / 12	LEU A 527 LEU A 429 LEU A 332 THR A 480 PHE A 482	None	1.29A	2oaxA-1f3lA: undetectable	2oaxA-1f3lA: 19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OAX_B_SNLB2001_1 (MINERALOCORTICOID RECEPTOR)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	5 / 12	LEU A 527 LEU A 429 LEU A 332 THR A 480 PHE A 482	None	1.32A	2oaxB-1f3lA: undetectable	2oaxB-1f3lA: 19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OAX_C_SNLC3001_1 (MINERALOCORTICOID RECEPTOR)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	5 / 12	LEU A 527 LEU A 429 LEU A 332 THR A 480 PHE A 482	None	1.30A	2oaxC-1f3lA: undetectable	2oaxC-1f3lA: 19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ADS_A_IMNA2_2 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	4 / 6	ILE A 416 ILE A 359 TYR A 455 LEU A 364	None	0.89A	3adsA-1f3lA: 0.0	3adsA-1f3lA: 20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ADS_B_IMNB3_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	5 / 12	ILE A 310 SER A 267 ILE A 303 VAL A 320 ILE A 323	SAH A 529 (-4.3A) None None None None	1.15A	3adsB-1f3lA: undetectable	3adsB-1f3lA: 20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EBZ_B_017B201_2 (PROTEASE)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	5 / 11	LEU A 266 ASP A 258 ALA A 280 ILE A 286 ILE A 265	SAH A 529 ( 4.4A) SAH A 529 ( 4.4A) None None SAH A 529 (-4.9A)	0.95A	3ebzB-1f3lA: undetectable	3ebzB-1f3lA: 14.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GSS_A_EAAA212_1 (GLUTATHIONE S-TRANSFERASE P1-1)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	4 / 7	TYR A 330 PHE A 334 ILE A 226 TYR A 221	None None None SAH A 529 (-3.5A)	0.77A	3gssA-1f3lA: 0.0	3gssA-1f3lA: 19.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GSS_B_EAAB211_1 (GLUTATHIONE S-TRANSFERASE P1-1)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	4 / 7	TYR A 330 PHE A 334 ILE A 226 TYR A 221	None None None SAH A 529 (-3.5A)	0.77A	3gssB-1f3lA: 0.0	3gssB-1f3lA: 19.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3K4V_B_ROCB201_1 (HIV-1 PROTEASE)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	6 / 12	LEU A 287 ASP A 282 GLY A 260 ILE A 226 ILE A 265 ILE A 286	None SAH A 529 (-2.7A) SAH A 529 (-3.1A) None SAH A 529 (-4.9A) None	1.39A	3k4vA-1f3lA: undetectable	3k4vA-1f3lA: 14.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N3I_A_ROCA201_2 (PROTEASE)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	4 / 6	ILE A 265 ILE A 310 GLY A 260 VAL A 256	SAH A 529 (-4.9A) SAH A 529 (-4.3A) SAH A 529 (-3.1A) None	0.73A	3n3iA-1f3lA: 0.0	3n3iA-1f3lA: 21.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N9J_A_EAAA210_1 (GLUTATHIONE S-TRANSFERASE P)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	4 / 8	TYR A 330 PHE A 334 ILE A 226 TYR A 221	None None None SAH A 529 (-3.5A)	0.87A	3n9jA-1f3lA: undetectable	3n9jA-1f3lA: 19.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3S45_B_478B201_2 (PROTEASE)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	5 / 11	LEU A 266 ASP A 258 ALA A 280 ILE A 286 ILE A 265	SAH A 529 ( 4.4A) SAH A 529 ( 4.4A) None None SAH A 529 (-4.9A)	0.93A	3s45B-1f3lA: undetectable	3s45B-1f3lA: 14.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TL9_A_ROCA401_1 (PROTEASE)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	6 / 12	LEU A 287 ASP A 282 GLY A 260 ILE A 226 ILE A 265 ILE A 286	None SAH A 529 (-2.7A) SAH A 529 (-3.1A) None SAH A 529 (-4.9A) None	1.31A	3tl9A-1f3lA: undetectable	3tl9A-1f3lA: 14.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VHU_A_SNLA1001_1 (MINERALOCORTICOID RECEPTOR)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	5 / 12	LEU A 527 LEU A 429 LEU A 332 THR A 480 PHE A 482	None	1.29A	3vhuA-1f3lA: undetectable	3vhuA-1f3lA: 20.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LV9_A_20JA602_1 (NICOTINAMIDE PHOSPHORIBOSYLTRANSF ERASE)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	4 / 7	TYR A 288 ILE A 294 ARG A 295 ILE A 293	None	0.87A	4lv9A-1f3lA: undetectable	4lv9A-1f3lA: 21.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O2B_B_LOCB503_1 (TUBULIN ALPHA-1B CHAIN TUBULIN BETA-2B CHAIN)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	3 / 3	SER A 368 ALA A 366 VAL A 365	None	0.53A	4o2bA-1f3lA: undetectable	4o2bA-1f3lA: 19.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O2B_D_LOCD503_1 (TUBULIN ALPHA-1B CHAIN TUBULIN BETA-2B CHAIN)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	3 / 3	SER A 368 ALA A 366 VAL A 365	None	0.54A	4o2bC-1f3lA: undetectable	4o2bC-1f3lA: 19.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4X1I_B_LOCB502_1 (TUBULIN ALPHA CHAIN TUBULIN BETA CHAIN)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	3 / 3	SER A 368 ALA A 366 VAL A 365	None	0.61A	4x1iA-1f3lA: 2.3	4x1iA-1f3lA: 19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4X20_D_LOCD502_1 (TUBULIN ALPHA CHAIN TUBULIN BETA CHAIN)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	3 / 3	SER A 368 ALA A 366 VAL A 365	None	0.62A	4x20C-1f3lA: 2.3	4x20C-1f3lA: 19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BW4_A_SAMA301_0 (16S RRNA (ADENINE(1408)-N(1)) -METHYLTRANSFERASE)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	5 / 12	GLY A 260 GLY A 262 ASP A 282 ILE A 310 GLU A 311	SAH A 529 (-3.1A) SAH A 529 ( 3.7A) SAH A 529 (-2.7A) SAH A 529 (-4.3A) SAH A 529 (-3.7A)	0.78A	5bw4A-1f3lA: 5.1	5bw4A-1f3lA: 21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CSW_A_P06A801_2 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	3 / 3	PHE A 452 ILE A 454 ASP A 420	None	0.57A	5cswA-1f3lA: undetectable	5cswA-1f3lA: 21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CSW_B_P06B801_2 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	3 / 3	PHE A 452 ILE A 454 ASP A 420	None	0.49A	5cswB-1f3lA: 0.0	5cswB-1f3lA: 21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EYP_B_LOCB502_1 (TUBULIN ALPHA CHAIN TUBULIN BETA CHAIN)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	3 / 3	SER A 368 ALA A 366 VAL A 365	None	0.59A	5eypA-1f3lA: 0.4	5eypA-1f3lA: 19.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Q1S_A_AWYA1103_0 (DNA CROSS-LINK REPAIR 1A PROTEIN)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	4 / 6	VAL A 317 LYS A 319 ILE A 279 TYR A 348	None	1.28A	5q1sA-1f3lA: 0.0	5q1sA-1f3lA: 21.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X7P_B_ACRB1421_1 (GLYCOSIDE HYDROLASE FAMILY 31 ALPHA-GLUCOSIDASE)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	4 / 6	MET A 230 GLU A 335 TYR A 221 GLY A 222	SAH A 529 (-3.7A) None SAH A 529 (-3.5A) None	0.96A	5x7pB-1f3lA: 0.1	5x7pB-1f3lA: 12.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DLZ_B_CYZB1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	5 / 10	LEU A 332 LEU A 429 ASP A 428 ILE A 454 PRO A 357	None	1.40A	6dlzB-1f3lA: undetectable 6dlzC-1f3lA: undetectable	6dlzB-1f3lA: 14.64 6dlzC-1f3lA: 14.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DLZ_D_CYZD1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	5 / 11	ILE A 454 PRO A 357 LEU A 332 LEU A 429 ASP A 428	None	1.39A	6dlzA-1f3lA: undetectable 6dlzD-1f3lA: undetectable	6dlzA-1f3lA: 14.64 6dlzD-1f3lA: 14.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DM1_B_CYZB1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	5 / 10	LEU A 332 LEU A 429 ASP A 428 ILE A 454 PRO A 357	None	1.40A	6dm1B-1f3lA: undetectable 6dm1C-1f3lA: undetectable	6dm1B-1f3lA: 14.64 6dm1C-1f3lA: 14.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DM1_D_CYZD1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	5 / 11	ILE A 454 PRO A 357 LEU A 332 LEU A 429 ASP A 428	None	1.39A	6dm1A-1f3lA: undetectable 6dm1D-1f3lA: undetectable	6dm1A-1f3lA: 14.64 6dm1D-1f3lA: 14.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DM2_B_CYZB1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	5 / 10	LEU A 332 LEU A 429 ASP A 428 ILE A 454 PRO A 357	None	1.43A	6dm2B-1f3lA: undetectable 6dm2C-1f3lA: undetectable	6dm2B-1f3lA: 14.64 6dm2C-1f3lA: 14.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DM2_D_CYZD1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	5 / 10	ILE A 454 PRO A 357 LEU A 332 LEU A 429 ASP A 428	None	1.42A	6dm2A-1f3lA: undetectable 6dm2D-1f3lA: undetectable	6dm2A-1f3lA: 14.64 6dm2D-1f3lA: 14.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FDY_U_DB8U302_1 (-)	1f3l	PROTEIN ARGININE METHYLTRANSFERASE PRMT3 (Rattus norvegicus)	5 / 9	LEU A 512 VAL A 502 SER A 363 LEU A 364 ILE A 500	None	1.17A	6fdyU-1f3lA: 0.0	6fdyU-1f3lA: 20.42

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["11GS_A_EAAA211_1","GLUTATHIONE S-TRANSFERASE","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",4,"TYR A 330;PHE A 334;ILE A 226;TYR A 221","None;None;None;SAH A 529 (-3.5A)","0.78A","11gsA-1f3lA:undetectable","11gsA-1f3lA:19.31"],["11GS_B_EAAB211_1","GLUTATHIONE S-TRANSFERASE","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",4,"TYR A 330;PHE A 334;ILE A 226;TYR A 221","None;None;None;SAH A 529 (-3.5A)","0.78A","11gsB-1f3lA:undetectable","11gsB-1f3lA:19.31"],["1A29_A_TFPA153_1","CALMODULIN","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",4,"ILE A 303;LEU A 299;ALA A 270;VAL A 278","None","0.74A","1a29A-1f3lA:undetectable","1a29A-1f3lA:16.46"],["1YAJ_A_BEZA11_0","CES1 PROTEIN","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",4,"LEU A 364;SER A 433;LEU A 518;LEU A 437","None","1.06A","1yajA-1f3lA:1.5","1yajA-1f3lA:20.00"],["1ZUC_B_T98B202_1","PROGESTERONE RECEPTOR","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",5,"LEU A 527;LEU A 512;LEU A 429;THR A 480;PHE A 482","None","1.11A","1zucB-1f3lA:undetectable","1zucB-1f3lA:20.06"],["2GSS_A_EAAA0_1","GLUTATHIONE S-TRANSFERASE P1-1","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",4,"TYR A 330;PHE A 334;ILE A 226;TYR A 221","None;None;None;SAH A 529 (-3.5A)","0.80A","2gssA-1f3lA:undetectable","2gssA-1f3lA:19.31"],["2GSS_B_EAAB0_1","GLUTATHIONE S-TRANSFERASE P1-1","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",4,"TYR A 330;PHE A 334;ILE A 226;TYR A 221","None;None;None;SAH A 529 (-3.5A)","0.80A","2gssB-1f3lA:undetectable","2gssB-1f3lA:19.31"],["2NMZ_B_ROCB401_1","PROTEASE;PROTEASE","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",6,"LEU A 287;ASP A 282;GLY A 260;ILE A 226;ILE A 265;ILE A 286","None;SAH A 529 (-2.7A);SAH A 529 (-3.1A);None;SAH A 529 (-4.9A);None","1.35A","2nmzA-1f3lA:undetectable","2nmzA-1f3lA:16.06"],["2OAX_A_SNLA1001_1","MINERALOCORTICOID RECEPTOR","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",5,"LEU A 527;LEU A 429;LEU A 332;THR A 480;PHE A 482","None","1.29A","2oaxA-1f3lA:undetectable","2oaxA-1f3lA:19.39"],["2OAX_B_SNLB2001_1","MINERALOCORTICOID RECEPTOR","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",5,"LEU A 527;LEU A 429;LEU A 332;THR A 480;PHE A 482","None","1.32A","2oaxB-1f3lA:undetectable","2oaxB-1f3lA:19.39"],["2OAX_C_SNLC3001_1","MINERALOCORTICOID RECEPTOR","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",5,"LEU A 527;LEU A 429;LEU A 332;THR A 480;PHE A 482","None","1.30A","2oaxC-1f3lA:undetectable","2oaxC-1f3lA:19.39"],["3ADS_A_IMNA2_2","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",4,"ILE A 416;ILE A 359;TYR A 455;LEU A 364","None","0.89A","3adsA-1f3lA:0.0","3adsA-1f3lA:20.69"],["3ADS_B_IMNB3_1","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",5,"ILE A 310;SER A 267;ILE A 303;VAL A 320;ILE A 323","SAH A 529 (-4.3A);None;None;None;None","1.15A","3adsB-1f3lA:undetectable","3adsB-1f3lA:20.69"],["3EBZ_B_017B201_2","PROTEASE","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",5,"LEU A 266;ASP A 258;ALA A 280;ILE A 286;ILE A 265","SAH A 529 ( 4.4A);SAH A 529 ( 4.4A);None;None;SAH A 529 (-4.9A)","0.95A","3ebzB-1f3lA:undetectable","3ebzB-1f3lA:14.15"],["3GSS_A_EAAA212_1","GLUTATHIONE S-TRANSFERASE P1-1","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",4,"TYR A 330;PHE A 334;ILE A 226;TYR A 221","None;None;None;SAH A 529 (-3.5A)","0.77A","3gssA-1f3lA:0.0","3gssA-1f3lA:19.31"],["3GSS_B_EAAB211_1","GLUTATHIONE S-TRANSFERASE P1-1","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",4,"TYR A 330;PHE A 334;ILE A 226;TYR A 221","None;None;None;SAH A 529 (-3.5A)","0.77A","3gssB-1f3lA:0.0","3gssB-1f3lA:19.31"],["3K4V_B_ROCB201_1","HIV-1 PROTEASE;HIV-1 PROTEASE","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",6,"LEU A 287;ASP A 282;GLY A 260;ILE A 226;ILE A 265;ILE A 286","None;SAH A 529 (-2.7A);SAH A 529 (-3.1A);None;SAH A 529 (-4.9A);None","1.39A","3k4vA-1f3lA:undetectable","3k4vA-1f3lA:14.33"],["3N3I_A_ROCA201_2","PROTEASE","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",4,"ILE A 265;ILE A 310;GLY A 260;VAL A 256","SAH A 529 (-4.9A);SAH A 529 (-4.3A);SAH A 529 (-3.1A);None","0.73A","3n3iA-1f3lA:0.0","3n3iA-1f3lA:21.36"],["3N9J_A_EAAA210_1","GLUTATHIONE S-TRANSFERASE P","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",4,"TYR A 330;PHE A 334;ILE A 226;TYR A 221","None;None;None;SAH A 529 (-3.5A)","0.87A","3n9jA-1f3lA:undetectable","3n9jA-1f3lA:19.31"],["3S45_B_478B201_2","PROTEASE","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",5,"LEU A 266;ASP A 258;ALA A 280;ILE A 286;ILE A 265","SAH A 529 ( 4.4A);SAH A 529 ( 4.4A);None;None;SAH A 529 (-4.9A)","0.93A","3s45B-1f3lA:undetectable","3s45B-1f3lA:14.15"],["3TL9_A_ROCA401_1","PROTEASE","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",6,"LEU A 287;ASP A 282;GLY A 260;ILE A 226;ILE A 265;ILE A 286","None;SAH A 529 (-2.7A);SAH A 529 (-3.1A);None;SAH A 529 (-4.9A);None","1.31A","3tl9A-1f3lA:undetectable","3tl9A-1f3lA:14.97"],["3VHU_A_SNLA1001_1","MINERALOCORTICOID RECEPTOR","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",5,"LEU A 527;LEU A 429;LEU A 332;THR A 480;PHE A 482","None","1.29A","3vhuA-1f3lA:undetectable","3vhuA-1f3lA:20.41"],["4LV9_A_20JA602_1","NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",4,"TYR A 288;ILE A 294;ARG A 295;ILE A 293","None","0.87A","4lv9A-1f3lA:undetectable","4lv9A-1f3lA:21.16"],["4O2B_B_LOCB503_1","TUBULIN ALPHA-1B CHAIN;TUBULIN BETA-2B CHAIN","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",3,"SER A 368;ALA A 366;VAL A 365","None","0.53A","4o2bA-1f3lA:undetectable","4o2bA-1f3lA:19.58"],["4O2B_D_LOCD503_1","TUBULIN ALPHA-1B CHAIN;TUBULIN BETA-2B CHAIN","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",3,"SER A 368;ALA A 366;VAL A 365","None","0.54A","4o2bC-1f3lA:undetectable","4o2bC-1f3lA:19.58"],["4X1I_B_LOCB502_1","TUBULIN ALPHA CHAIN;TUBULIN BETA CHAIN","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",3,"SER A 368;ALA A 366;VAL A 365","None","0.61A","4x1iA-1f3lA:2.3","4x1iA-1f3lA:19.38"],["4X20_D_LOCD502_1","TUBULIN ALPHA CHAIN;TUBULIN BETA CHAIN","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",3,"SER A 368;ALA A 366;VAL A 365","None","0.62A","4x20C-1f3lA:2.3","4x20C-1f3lA:19.38"],["5BW4_A_SAMA301_0","16S RRNA (ADENINE(1408)-N(1))-METHYLTRANSFERASE","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",5,"GLY A 260;GLY A 262;ASP A 282;ILE A 310;GLU A 311","SAH A 529 (-3.1A);SAH A 529 ( 3.7A);SAH A 529 (-2.7A);SAH A 529 (-4.3A);SAH A 529 (-3.7A)","0.78A","5bw4A-1f3lA:5.1","5bw4A-1f3lA:21.39"],["5CSW_A_P06A801_2","SERINE\/THREONINE-PROTEIN KINASE B-RAF","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",3,"PHE A 452;ILE A 454;ASP A 420","None","0.57A","5cswA-1f3lA:undetectable","5cswA-1f3lA:21.34"],["5CSW_B_P06B801_2","SERINE\/THREONINE-PROTEIN KINASE B-RAF","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",3,"PHE A 452;ILE A 454;ASP A 420","None","0.49A","5cswB-1f3lA:0.0","5cswB-1f3lA:21.34"],["5EYP_B_LOCB502_1","TUBULIN ALPHA CHAIN;TUBULIN BETA CHAIN","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",3,"SER A 368;ALA A 366;VAL A 365","None","0.59A","5eypA-1f3lA:0.4","5eypA-1f3lA:19.58"],["5Q1S_A_AWYA1103_0","DNA CROSS-LINK REPAIR 1A PROTEIN","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",4,"VAL A 317;LYS A 319;ILE A 279;TYR A 348","None","1.28A","5q1sA-1f3lA:0.0","5q1sA-1f3lA:21.59"],["5X7P_B_ACRB1421_1","GLYCOSIDE HYDROLASE FAMILY 31 ALPHA-GLUCOSIDASE","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",4,"MET A 230;GLU A 335;TYR A 221;GLY A 222","SAH A 529 (-3.7A);None;SAH A 529 (-3.5A);None","0.96A","5x7pB-1f3lA:0.1","5x7pB-1f3lA:12.98"],["6DLZ_B_CYZB1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",5,"LEU A 332;LEU A 429;ASP A 428;ILE A 454;PRO A 357","None","1.40A","6dlzB-1f3lA:undetectable;6dlzC-1f3lA:undetectable","6dlzB-1f3lA:14.64;6dlzC-1f3lA:14.64"],["6DLZ_D_CYZD1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",5,"ILE A 454;PRO A 357;LEU A 332;LEU A 429;ASP A 428","None","1.39A","6dlzA-1f3lA:undetectable;6dlzD-1f3lA:undetectable","6dlzA-1f3lA:14.64;6dlzD-1f3lA:14.64"],["6DM1_B_CYZB1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",5,"LEU A 332;LEU A 429;ASP A 428;ILE A 454;PRO A 357","None","1.40A","6dm1B-1f3lA:undetectable;6dm1C-1f3lA:undetectable","6dm1B-1f3lA:14.64;6dm1C-1f3lA:14.64"],["6DM1_D_CYZD1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",5,"ILE A 454;PRO A 357;LEU A 332;LEU A 429;ASP A 428","None","1.39A","6dm1A-1f3lA:undetectable;6dm1D-1f3lA:undetectable","6dm1A-1f3lA:14.64;6dm1D-1f3lA:14.64"],["6DM2_B_CYZB1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",5,"LEU A 332;LEU A 429;ASP A 428;ILE A 454;PRO A 357","None","1.43A","6dm2B-1f3lA:undetectable;6dm2C-1f3lA:undetectable","6dm2B-1f3lA:14.64;6dm2C-1f3lA:14.64"],["6DM2_D_CYZD1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",5,"ILE A 454;PRO A 357;LEU A 332;LEU A 429;ASP A 428","None","1.42A","6dm2A-1f3lA:undetectable;6dm2D-1f3lA:undetectable","6dm2A-1f3lA:14.64;6dm2D-1f3lA:14.64"],["6FDY_U_DB8U302_1","-","1f3l","PROTEIN ARGININE METHYLTRANSFERASE PRMT3","Rattus norvegicus",5,"LEU A 512;VAL A 502;SER A 363;LEU A 364;ILE A 500","None","1.17A","6fdyU-1f3lA:0.0","6fdyU-1f3lA:20.42"]]